Eotaxin Triggers Eosmophil-Selective Chemotaxis and Calcium Flux via a Distinct Receptor and Induces Pulmonary Eosinophilia in the Presence of Interleukin 5 in Mice

[1]  P. Leder,et al.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.

[2]  W Newman,et al.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. , 1996, The Journal of clinical investigation.

[3]  P. Foster,et al.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.

[4]  N. Copeland,et al.  Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. , 1996, Immunity.

[5]  P. Hodgkin,et al.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.

[6]  A. Luster,et al.  Molecular characterization of two murine eosinophil beta chemokine receptors. , 1995, Journal of immunology.

[7]  T. Williams,et al.  Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo , 1995, The Journal of experimental medicine.

[8]  P. Leder,et al.  Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Power,et al.  Molecular Cloning and Functional Expression of a Novel CC Chemokine Receptor cDNA from a Human Basophilic Cell Line (*) , 1995, The Journal of Biological Chemistry.

[10]  C. Combadière,et al.  Cloning, chromosomal localization, and RNA expression of a human beta chemokine receptor-like gene. , 1995, DNA and cell biology.

[11]  C. Combadière,et al.  Cloning and Functional Expression of a Human Eosinophil CC Chemokine Receptor (*) , 1995, The Journal of Biological Chemistry.

[12]  I. van Ark,et al.  Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice. , 1995, The Journal of allergy and clinical immunology.

[13]  P. Leder,et al.  The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation , 1995, The Journal of experimental medicine.

[14]  M. Baggiolini,et al.  Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. , 1995, Journal of immunology.

[15]  P. Leder,et al.  Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung , 1995, The Journal of experimental medicine.

[16]  J. Gong,et al.  Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues , 1995, Journal of Experimental Medicine.

[17]  I. Adcock,et al.  Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. , 1994, Biochemical and biophysical research communications.

[18]  D. Largaespada,et al.  Lymphotactin: a cytokine that represents a new class of chemokine. , 1994, Science.

[19]  T. Schall,et al.  Biologic activities of the murine beta-chemokine TCA3. , 1994, Journal of immunology.

[20]  B. Sykes,et al.  Neutrophil activation by monomeric interleukin-8. , 1994, Science.

[21]  B. Rollins,et al.  Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. , 1994, The Journal of biological chemistry.

[22]  S. Coughlin,et al.  Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Hsuan,et al.  Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.

[24]  M. Baggiolini,et al.  CC chemokines in allergic inflammation. , 1994, Immunology today.

[25]  A. Minty,et al.  Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine , 1994, The Journal of experimental medicine.

[26]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[27]  P. Murphy.  The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.

[28]  T. Schall,et al.  Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor , 1993, Cell.

[29]  S. Georas,et al.  Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. , 1992, Journal of immunology.

[30]  T. Schall,et al.  RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes , 1992, The Journal of experimental medicine.

[31]  S. Stafford,et al.  Macrophage inflammatory protein-1 alpha activates basophils and mast cells , 1992, The Journal of experimental medicine.

[32]  C. Sanderson.  Interleukin-5, Eosinophils, and Disease , 1992 .

[33]  Hongyung Choi,et al.  A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. , 1992, Journal of immunology.

[34]  A. Wardlaw,et al.  Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. , 1992, Blood.

[35]  T. Brunner,et al.  Monocyte chemotactic protein 1 is a potent activator of human basophils , 1992, The Journal of experimental medicine.

[36]  R. Alam,et al.  Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. , 1992, The Journal of clinical investigation.

[37]  T. Suda,et al.  Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. , 1991, Blood.

[38]  R. Hajjar,et al.  Noncyclooxygenase metabolites of arachidonic acid amplify the vasopressin-induced Ca2+ signal in glomerular mesangial cells by releasing Ca2+ from intracellular stores. , 1991, The Journal of biological chemistry.

[39]  M. Strath,et al.  Eosinophilia in transgenic mice expressing interleukin 5 , 1990, The Journal of experimental medicine.

[40]  W. Owen,et al.  IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. , 1989, Journal of immunology.

[41]  P. Kallós,et al.  Experimental asthma in guinea pigs revisited. , 1984, International archives of allergy and applied immunology.

[42]  H. Schild.  Receptor Classification with Special Reference to β-Adrenergic Receptors , 1973 .